MATT ANENETE VON,WOLF ROMAIN,SOLDERMANN NICOLAS,HEBACH CHRISTINA,HOGENAUER KLEMENS,HOLLINGWORTH GREGORY,KALIS CHRISTOPH,LEWIS IAN,SMITH ALEXANDER BAXTER,SOLDERMANN NICOLAS,STAUFFER FREDERIC,STRANG ROS
申请号：
AP201407679
公开号：
AP201407679A0
申请日:
2012.12.14
申请国别(地区):
AP
年份:
2014
代理人:
摘要：
The invention relates to new uses of PI3K inhibitors, wherein said inhibitors have an inhibitory action on the PI3K isoform delta for the treatment of immunopathology in a subject suffering from a disease or disorder selected from malaria, leishmaniasis, trypanosomiasis, toxoplasmosis and/or neurocysticercosis, via functional inhibition of TLR9 of the infected subject.
